Skip to main content
. 2025 Aug 22;11:99. doi: 10.1186/s40798-025-00906-w

Table 2.

Methodological quality assessment of included studies judged using TESTEX scale

Study quality Study reporting
Study Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Overall Judgement
Alves et al. [25] 1 1 0 1 0 0 0 1 1 0 0 1 6 Fair
Bittman et al. [37] 1 1 0 1 1 2 0 1 1 1 0 1 10 Good
Joensen et al. [38] 1 0 0 1 1 2 0 1 1 0 0 1 8 Fair
Kato et al. [39] 1 0 0 1 1 3 0 1 1 0 0 1 9 Good
Kim et al. [40] 1 1 0 1 1 0 0 1 1 0 0 1 7 Fair
Malmo et al. [41] 1 0 0 1 1 3 0 1 1 0 0 1 9 Good
Nourmohammadi et al. [42] 1 1 0 1 0 0 0 1 1 0 0 1 6 Fair
Osbak et al. [43] 1 1 1 1 1 2 0 1 1 0 0 1 10 Good
Risom et al. [44] 1 1 1 1 0 2 2 1 1 0 0 1 11 Good
Borland et al. [45] 1 1 1 1 1 3 2 1 1 NA 0 1 13 Excellent
Reed et al. [26] 1 1 1 1 1 0 2 1 1 NA 0 1 10 Good
Skielboe et al. [46] 1 1 1 1 1 2 2 1 1 NA 0 1 12 Excellent

Item 1, eligibility criteria specified; Item 2, randomisation specified; Item 3, allocation concealment; Item 4, group similar at baseline; Item 5, blinding of assessor; Item 6, outcome measures assessed in 85% of patients; Item 7, intention-to-treat analysis; Item 8, between-group statistical comparisons reported; Item 9, point measures and measures of variability for all reported outcome measures; Item 10, activity monitoring in control groups; Item 11, relative exercise intensity remained constant; Item 12, exercise volume and energy expenditure; NA, non-applicable item due to study design